BURLINGTON, Mass. and JERUSALEM, Aug. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the appointment of Richard A. Bermudes, M.D. as Chief Medical Officer (CMO), effective September 1, 2024. Dr. Aron Tendler, M.D., who has served as CMO since 2015, will continue to serve as a collaborator on important strategic research projects. "We are excited ...

On Friday, in his speech at the Fed's Jackson Hole Economic Policy Symposium, Chairman Jerome Powell signaled the first reduction in the benchmark interest rate since March 2020. The Fed fund rate is currently in the range of 5.25-5.5%, its highest level in 23 years. Although Powell refrained from announcing the time and the extent of the rate cut, Wall Street expects the first cut in the September FOMC meeting. A rate cut is likely to benefit small-cap stocks the most, aside from largecaps. At this stage, ...

Shares of Brainsway Ltd. Sponsored ADR (BWAY) have gained 0.9% over the past four weeks to close the last trading session at $8.02, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $12.90 indicates a potential upside of 60.9%. The average comprises four short-term price targets ranging from a low of $11 to a high of $16, with a standard deviation of $2.17. While the lowest estima ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Brainsway Ltd. Sponsored ADR (BWAY) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Brainsway Ltd. Sponsored ADR is one of 1018 companies in the Medical ...

Have you been paying attention to shares of Brainsway Ltd. Sponsored ADR (BWAY) ? Shares have been on the move with the stock up 21.1% over the past month. The stock hit a new 52-week high of $8.28 in the previous session. Brainsway Ltd. Sponsored ADR has gained 21.5% since the start of the year compared to the 9.5% move for the Zacks Medical sector and the 8.4% return for the Zacks Medical - Products industry. What's Driving the Outperformance? The stock has an impressive record of positive earnings surpri ...

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done. The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the s ...

PM Images/DigitalVision via Getty Images BrainsWay (NASDAQ:BWAY) (OTCPK:BRSYF) reported strong earnings again in the second quarter, particularly from a margin perspective. This strength is particularly notable given Neuronetics (STIM) recent struggles. BrainsWay's revenue was up 28% YoY, and while growth is moderating, this is coming against increasingly difficult comparable periods. I previously suggested that BrainsWay's stock should continue to rerate higher as the company's profitable growth trajectory ...

Investors might want to bet on Brainsway Ltd. Sponsored ADR (BWAY) , as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this trend might continue with its still improving earnings outlook. Analysts' growing optimism on the earnings prospects of this company is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earni ...

Brainsway Ltd. Sponsored ADR (BWAY) closed the last trading session at $6.82, gaining 10.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $11.75 indicates a 72.3% upside potential. The average comprises four short-term price targets ranging from a low of $9 to a high of $15, with a standard deviation of $2.50. While the lowest estimate indicates an increase of 32% from the curren ...

BrainsWay Ltd. (NASDAQ:BWAY) Q2 2024 Earnings Call Transcript August 6, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Steve Lichtman - Oppenheimer Jeffery S. Cohen - Ladenburg Thalmann & Company Operator Good day and welcome to the BrainsWay Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask ...